134 related articles for article (PubMed ID: 31523886)
41. Long-term patterns of safety and efficacy of bleeding prophylaxis with turoctocog alfa (NovoEight(®) ) in previously treated patients with severe haemophilia A: interim results of the guardian(™) 2 extension trial.
Ozelo M; Misgav M; Abdul Karim F; Lentz SR; Martin-Salces M; Matytsina I; Saugstrup T; Santagostino E
Haemophilia; 2015 Sep; 21(5):e436-9. PubMed ID: 26058730
[No Abstract] [Full Text] [Related]
42. Temporarily successful eradication therapy in acquired haemophilia with high inhibitor titer: a case report with a new protocol.
Ilonczai P; Schlammadinger A; Oláh Z; Rázsó K; Bereczky Z; Boda Z
Thromb Haemost; 2008 Jul; 100(1):149-50. PubMed ID: 18612550
[No Abstract] [Full Text] [Related]
43. The overall effectiveness of prophylaxis in severe haemophilia.
Panicker J; Warrier I; Thomas R; Lusher JM
Haemophilia; 2003 May; 9(3):272-8. PubMed ID: 12694517
[TBL] [Abstract][Full Text] [Related]
44. Non-haematological pathologies -- 'the importance of musculoskeletal assessment in haemophilia'.
Dalzell R
Haemophilia; 2005 Nov; 11(6):620-2. PubMed ID: 16236112
[No Abstract] [Full Text] [Related]
45. Haemophilia.
Jones P
Physiotherapy; 1976 Jun; 62(7):214-6. PubMed ID: 967940
[No Abstract] [Full Text] [Related]
46. The current status of prophylactic replacement therapy in children and adults with haemophilia.
Ljung R; Gretenkort Andersson N
Br J Haematol; 2015 Jun; 169(6):777-86. PubMed ID: 25819695
[TBL] [Abstract][Full Text] [Related]
47. Life-threatening oro-pharyngeal bleeding in a haemophiliac with factor VIII inhibitors.
Roderick PJ; Robinson AC
Clin Lab Haematol; 1988; 10(2):217-9. PubMed ID: 3138066
[No Abstract] [Full Text] [Related]
48. Comparison of the efficacy and safety of 12-month low-dose factor VIII tertiary prophylaxis vs on-demand treatment in severe haemophilia A children.
Chozie NA; Primacakti F; Gatot D; Setiabudhy RD; Tulaar ABM; Prasetyo M
Haemophilia; 2019 Jul; 25(4):633-639. PubMed ID: 31044491
[TBL] [Abstract][Full Text] [Related]
49. Interim results from a large multinational extension trial (guardian(™) 2) using turoctocog alfa for prophylaxis and treatment of bleeding in patients with severe haemophilia A.
Lentz SR; Cerqueira M; Janic D; Kempton C; Matytsina I; Misgav M; Oldenburg J; Ozelo M; Recht M; Rosholm A; Savic A; Suzuki T; Tiede A; Santagostino E
Haemophilia; 2016 Sep; 22(5):e445-9. PubMed ID: 27291066
[No Abstract] [Full Text] [Related]
50. How to manage invasive procedures in children with haemophilia.
Ljung RC; Knobe K
Br J Haematol; 2012 Jun; 157(5):519-28. PubMed ID: 22390160
[TBL] [Abstract][Full Text] [Related]
51. Lumbar puncture in haemophilia A: controversy in the management.
Beshlawi I; Al Lamki Z; Rawas A; Abdel-Baki MS; Wali Y
Haemophilia; 2014 Mar; 20(2):e175-7. PubMed ID: 24372668
[No Abstract] [Full Text] [Related]
52. Haemophilia Centre Director's annual statistics for 1975.
Biggs R; Spooner RJ
Br J Haematol; 1977 Jul; 36(3):447-9. PubMed ID: 889713
[No Abstract] [Full Text] [Related]
53. [Hemophilia, a changed picture].
Breederveld C; ten Cate JW; Sixma JJ; Veltkamp JJ
Ned Tijdschr Geneeskd; 1976 Jan; 120(2):69-70. PubMed ID: 1250448
[No Abstract] [Full Text] [Related]
54. Inhibitors in haemophilia: a primer.
DiMichele DM
Haemophilia; 2000 Jul; 6 Suppl 1():38-40. PubMed ID: 10982266
[No Abstract] [Full Text] [Related]
55. Changes in CD4 count relative to product usage: findings from the transfusion safety study.
Hilgartner MW
Semin Hematol; 1993 Oct; 30(4 Suppl 5):7-9. PubMed ID: 7903481
[No Abstract] [Full Text] [Related]
56. [Diagnostic image (379). A confused man with tetraparesis and haemophilia].
Holwerda TJ; van Geel BM
Ned Tijdschr Geneeskd; 2008 Jul; 152(27):1518. PubMed ID: 18681361
[TBL] [Abstract][Full Text] [Related]
57. Orthopaedic evaluation in children with severe haemophilia A or B submitted to primary prophylaxis therapy in a coagulopathy treatment centre.
De Podestá Haje D; Ono F; De Oliveira GB; Almeida J; De Paula JC; Batista Neto LV; Silva Barros SB
Haemophilia; 2011 Mar; 17(2):228-32. PubMed ID: 21070500
[TBL] [Abstract][Full Text] [Related]
58. Hemostasis. II. The use of factor VIII concentrates in the therapy of hemophilia.
Davis RB
Nebr State Med J; 1971 Jun; 56(6):219-24. PubMed ID: 4253029
[No Abstract] [Full Text] [Related]
59. Management of haemophilia.
Jones P
Arch Dis Child; 1984 Nov; 59(11):1010-2. PubMed ID: 6439126
[No Abstract] [Full Text] [Related]
60. Infusion of clotting factor concentrates in haemophilia.
Gomperts ED
Br J Haematol; 1992 Aug; 81(4):625. PubMed ID: 1390258
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
